← Open Payments lookup

GHIRMAY HAILE: Open Payments

NPI 1336611169 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$609 in 36 payments from 9 companies in 2025. Trend: 2023 $367 · 2024 $416 · 2025 $609

Food & beverage: $609
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$222
ABBVIE INC.11$148
Neurocrine BioSciences, Inc.3$68
E.R. Squibb & Sons, L.L.C.2$49
Vanda Pharmaceuticals Inc.3$47
Janssen Pharmaceuticals, Inc2$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
Alkermes, Inc.1$14
Otsuka America Pharmaceutical, Inc.1$13

Products named: VRAYLAR, UZEDY, INGREZZA, AUSTEDO XR, COBENFY, FANAPT, INVEGA SUSTENNA, CAPLYTA.

Industry payments across NM — which companies pay providers there.